Pharmaceutical company GlaxoSmithKline PLC has received European approval for Duodart, a two-in-one drug for the treatment of the symptoms of an enlarged prostate.
The Beckman Coulter Antibody Cocktail Preparation Workstation automatically combines antibodies and staining dyes from individual vials into tubes or vials staged on the company’s Biomek NXp deck.
The days of endless focus adjustments, jumpy live images, poor color fidelity on screen, and awkward fumbling with software are gone, thanks to the new Olympus DP21 high definition microscope digital camera.
Sigma Life Science, the biological products and services brand of Sigma-Aldrich, announced details of a corporate partnership with the European Molecular Biology Laboratory (EMBL) Advanced Training Centre, based in Heidelberg, Germany.
Thermo Fisher Scientific Inc., a leader in serving science, announced that up to data has become a member of its Informatics Global Partner Alliance Program.
Recent clinical studies in patients with bipolar disorder have suggested that phenytoin may have mood-stabilizing effects in addition to its well-known anticonvulsant properties.
A team of scientists including University of Utah researchers has discovered that binding of a potent inhibitor of the hepatitis C virus (HCV) to the genetic material of the virus causes a major conformational change that may adversely affect the ability of the virus to replicate.
Investigators believe they have identified the founding member of a chemical family they hope will lead to a new class of cancer drugs, the first designed specifically against a childhood tumor, according to research led by St. Jude Children's Research Hospital scientists.
In a ruling with potentially far-reaching implications for the patenting of human genes, a judge struck down a company's patents on two genes linked to an increased risk of breast and ovarian cancer.
Prosensa, a Netherlands-based biopharmaceutical company focusing on RNA modulating therapeutics, announces the start of a phase I/II clinical study for PRO044 in patients with Duchenne Muscular Dystrophy.
AstraZeneca PLC and Abbott Laboratories said that the U.S. Food and Drug Administration has asked for more information about their Certriad cholesterol drug before approving it for sale.
BioFocus announced that it has signed a three year compound management agreement with the Global Alliance for TB Drug Development (TB Alliance).
A collaborative project between Sanford-Burnham Medical Research Institute at Lake Nona and Analiza, Inc. has yielded aqueous solubility data for over 20,000 compounds in the NIH Molecular Library within the first 90 days of screening and characterization.
Evotec signs an agreement with Hypha Discovery to provide its screening clients with access to Hypha’s MycoDiverse natural product collection for use as part of its hit and lead identification services.
Just like the rest of us, scientists today are swamped with information. As more chemical resources become freely available, text mining applications - previously focused on correctly identifying gene and protein names – are now shifting towards also correctly identifying chemical names.